AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 68 filers reported holding AVIDITY BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,154,066 | +57427.1% | 1,121,327 | 0.0% | 0.38% | -34.0% |
| Q2 2023 | $12,436 | -27.7% | 1,121,327 | 0.0% | 0.58% | -31.8% |
| Q1 2023 | $17,212 | -99.9% | 1,121,327 | 0.0% | 0.85% | -35.5% |
| Q4 2022 | $24,882,246 | +35.9% | 1,121,327 | 0.0% | 1.31% | +27.4% |
| Q3 2022 | $18,311,000 | +12.4% | 1,121,327 | 0.0% | 1.03% | -0.2% |
| Q2 2022 | $16,293,000 | -21.3% | 1,121,327 | 0.0% | 1.03% | -3.0% |
| Q1 2022 | $20,711,000 | -22.3% | 1,121,327 | 0.0% | 1.06% | +2.8% |
| Q4 2021 | $26,654,000 | -3.5% | 1,121,327 | 0.0% | 1.04% | +7.4% |
| Q3 2021 | $27,618,000 | -0.3% | 1,121,327 | 0.0% | 0.96% | -1.4% |
| Q2 2021 | $27,708,000 | +13.3% | 1,121,327 | 0.0% | 0.98% | +18.0% |
| Q1 2021 | $24,456,000 | -14.5% | 1,121,327 | 0.0% | 0.83% | -9.9% |
| Q4 2020 | $28,616,000 | -9.3% | 1,121,327 | 0.0% | 0.92% | -15.7% |
| Q3 2020 | $31,565,000 | -0.4% | 1,121,327 | 0.0% | 1.09% | -21.7% |
| Q2 2020 | $31,689,000 | – | 1,121,327 | – | 1.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 854,651 | $5,452,673 | 6.70% |
| COWEN AND COMPANY, LLC | 5,629,103 | $35,913,677 | 2.51% |
| 5AM Venture Management, LLC | 665,555 | $4,246,241 | 1.22% |
| RTW INVESTMENTS, LP | 6,689,789 | $42,680,854 | 0.90% |
| Casdin Capital, LLC | 1,250,000 | $7,975,000 | 0.88% |
| RA Capital Management | 6,416,998 | $40,940,447 | 0.81% |
| Cormorant Asset Management, LP | 1,762,115 | $11,242,294 | 0.66% |
| Boxer Capital, LLC | 1,121,327 | $7,154,066 | 0.38% |
| AtonRa Partners | 18,970 | $121,029 | 0.25% |
| Avoro Capital Advisors LLC | 2,510,000 | $16,013,800 | 0.25% |